Cetera Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12M | Sell |
9,754
-821
| -8% | -$431K | 0.01% | 1174 |
|
|
2025
Q1 | $6.71M | Buy |
10,575
+1,336
| +14% | +$847K | 0.01% | 954 |
|
|
2024
Q4 | $6.58M | Buy |
9,239
+494
| +6% | +$352K | 0.01% | 902 |
|
|
2024
Q3 | $9.19M | Buy |
8,745
+799
| +10% | +$840K | 0.02% | 735 |
|
|
2024
Q2 | $8.35M | Sell |
7,946
-1,807
| -19% | -$1.9M | 0.02% | 746 |
|
|
2024
Q1 | $9.39M | Buy |
9,753
+5,955
| +157% | +$5.73M | 0.02% | 692 |
|
|
2023
Q4 | $3.34M | Buy |
3,798
+118
| +3% | +$104K | 0.03% | 590 |
|
|
2023
Q3 | $3.03M | Sell |
3,680
-114
| -3% | -$93.8K | 0.03% | 594 |
|
|
2023
Q2 | $2.73M | Buy |
3,794
+90
| +2% | +$64.7K | 0.02% | 640 |
|
|
2023
Q1 | $3.04M | Buy |
3,704
+509
| +16% | +$418K | 0.03% | 566 |
|
|
2022
Q4 | $2.31M | Buy |
3,195
+1,771
| +124% | +$1.28M | 0.02% | 650 |
|
|
2022
Q3 | $981K | Sell |
1,424
-1,315
| -48% | -$906K | 0.02% | 725 |
|
|
2022
Q2 | $1.62M | Sell |
2,739
-282
| -9% | -$167K | 0.03% | 608 |
|
|
2022
Q1 | $2.11M | Sell |
3,021
-62
| -2% | -$43.3K | 0.03% | 546 |
|
|
2021
Q4 | $1.95M | Buy |
3,083
+459
| +17% | +$290K | 0.03% | 561 |
|
|
2021
Q3 | $1.59M | Buy |
2,624
+54
| +2% | +$32.7K | 0.03% | 604 |
|
|
2021
Q2 | $1.44M | Sell |
2,570
-189
| -7% | -$106K | 0.02% | 636 |
|
|
2021
Q1 | $1.31M | Buy |
2,759
+483
| +21% | +$228K | 0.03% | 564 |
|
|
2020
Q4 | $1.1M | Buy |
+2,276
| New | +$1.1M | 0.02% | 632 |
|